Skip to main content
. 2019 Aug 16;10:1954. doi: 10.3389/fimmu.2019.01954

Figure 2.

Figure 2

Heterogeneous impact of adoptive transfer of CD4+ TReg on bone healing outcome in mice kept under non-SPF housing conditions. (A–D) μCT evaluation of the healing outcome after adoptive CD4+ TReg transfer after 21 d. (A) Representative images of the analyzed volume of interest of the healing bones are shown. +TReg treated mice clustered into responder (+TReg left, n = 4) and non-responder (+TReg right, n = 4). Control mice showed no complete bridging after 21 d (left, control, n = 6). In contrast, +TReg responder showed complete bridging, whereas non-responder showed no bridging. (B–D) Quantification of the μCT analysis, + TReg responder vs. + TReg non-responder vs. control mice. (E–G) Evaluation of the immune cell composition of +TReg responder vs. non-responder 21 d post-surgery. (E) Confirmation of CD4+ TReg engraftment in both, +TReg responder and non-responder compared to the control. (F,G) +TReg non-responder showed an elevated percentage of CD8+ TEFF (F) as well as a significantly higher ratio of CD8+ TEFF /CD4+ TReg (G) in the peripheral blood in comparison to the +TReg responder. TV, total volume; BV, bone volume; BV/TV, ratio of BV to TV; Mann–Whitney U-test, Bonferroni correction (B–E).